Severe Asthma ToolkitSevere Asthma Toolkit
HomeAboutSpecific PopulationsRegistriesContributorsContact
Twitter
  • What is Severe Asthma?
    • Overview
    • Definition
    • Prevalence & Burden
    • Pathophysiology
    • Symptoms
    • Severe Asthma Attacks / Exacerbations / Flare-ups
    • Asthma Phenotypes
  • Diagnosis & Assessment
    • Overview
    • Diagnosis Overview
    • Assessment Overview
    • Lung Function Assessments
    • Questionnaires
    • Allergy Assessments
    • Phenotyping
    • Bronchoscopy
    • Imaging
    • Occupational Asthma
  • Management
    • Overview
    • Asthma Education
      • About Severe Asthma
      • Asthma Pathophysiology
      • Medications Education
      • Self-Monitoring
      • Triggers
      • Review
    • Written Action Plans
    • Adherence
    • Inhaler Technique
    • Physical Activity & Exercise
    • Interdisciplinary Approach & Multidimensional Assessment
    • Referral
  • Medications
    • Overview
    • Relievers
    • Preventers / Controllers
    • Add-on Therapies
    • Monoclonal Antibodies
    • Bronchial Thermoplasty
  • Co-Morbidities
    • Overview
    • Pulmonary & Upper Airways
      • Allergic & Non-Allergic Rhinitis
      • Chronic Rhinosinusitis
      • Dysfunctional Breathing
      • Vocal Cord Dysfunction
      • Chronic Obstructive Pulmonary Disease
      • Bronchiectasis
      • Obstructive Sleep Apnoea
    • Extra-Pulmonary
      • Obesity
      • Anxiety & Depression
      • Gastro-oesophageal Reflux Disease (GORD)
      • Osteoporosis
      • Cardiovascular Disease & Metabolic Disease
  • Living with Severe Asthma
    • Overview
    • Daily Symptom Burden
    • Mental & Emotional Health
    • Intimacy & Relationships
    • Self-Management Support
    • Medication Use & Costs
    • Experience of Care
    • Experience of Asthma Attacks
    • Prognosis
  • Establishing a Clinic
    • Overview
    • Set-up
    • Staffing & Multidisciplinary Team Approach
    • Facilities
    • Delivery Approach
    • Tailored Referrals
    • Evaluation
    • Opportunities for Training & Research
    • Barriers & Hurdles
  • Paediatrics
    • Overview
    • Management in Paediatrics
    • Assessment in Paediatrics
    • Alternative Diagnosis & Co-Morbidities in Paediatrics
    • Psychosocial Issues in Paediatrics
    • Medications in Paediatrics
    • Asthma in the Adolescent Population
  • Resources
    • Overview
    • Clinic Recommendations
    • Infographics
    • Asthma Assessment Resources
    • Systematic & Multidimensional Assessment Resources
      • Airway Components
      • Comorbidity Components
      • Risk Factor Components
    • Translation & Implementation
    • Case Studies
    • Presentations
    • Videos
    • Relevant Links
    • Key References

Registries

Home Registries
Registries

What is a Severe Asthma Registry?

A severe asthma registry is an organised system for tracking the clinical care and outcomes of people with severe asthma.

Registries use ‘real-world’ observational data from many sites around the country. The sources of information may include patient medical records, patient-reported data and physician-reported data. The information collected may be utilised to answer research questions about the population and/or monitor and report on healthcare quality and patient management.

Why?

The World Health Organization has noted that ‘Severe asthma registries provide a foundation to generate a greater understanding of public health need, and to define phenotypic heterogeneity’ (Bousquet et al. 2010).   Severe asthma networks, including those in the UK/Europe, North America and Australasia have established severe asthma registries/patient cohorts to characterise the severe asthma patient population (Dolan et al. 2004, Heaney et al. 2010, Schleich et al. 2014, Senna et al. 2017).

Real-world representation of severe asthma

The access to new and emerging severe asthma treatments such as biologic therapies is guided by eligibility criteria derived from randomised controlled trials (RCTs), however only 10% of patients with severe asthma are thought to meet these criteria (Albers et al. 2018).

Practice-based information collected through severe asthma registries can provide insight into the proportion of patients who would be eligible for and/or benefit from these expensive treatments.

Australasian Severe Asthma Registries

Severe Asthma Web-Based Database (SAWD)
Severe Asthma Web-Based Database (SAWD)

The Australasian Severe Asthma Network (ASAN) is group of respiratory physicians and professionals with expertise in severe asthma across more than 30 centres in Australia, New Zealand, Singapore and China.  The ASAN’s Severe Asthma Web-Based Database (SAWD) is an ongoing investigator-initiated observational registry of patients with severe refractory asthma and controlled non-severe asthma.

Read more
Registries for biologic therapies
Australian Mepolizumab Registry (AMR)
Australian Xolair Registry (AXR)
Registries for bronchial thermoplasty
Australian Mepolizumab Registry (AMR)

The ASAN Australian Mepolizumab Registry (AMR) is currently enrolling patients in Australia with severe refractory eosinophilic asthma who are prescribed mepolizumab (Nucala).

Read more
Australian Xolair Registry (AXR)

Registries for patients with severe refractory allergic asthma who are prescribed omalizumab, such as the Australian Xolair Registry (AXR), have provided useful post-marketing information regarding this treatment and patient group.

Read more
Registries for bronchial thermoplasty

The international ERS/ATS guidelines on severe asthma recommend that bronchial thermoplasty (BT) be performed in the context of independent approved systematic registries or studies (Chung et al. 2014).  Data from patients who undergo BT is being collected through severe asthma registries such as the UK Severe Asthma Registry (Burn et al. 2017) and SAWD.

Read more

Key Points

  • Severe asthma registries allow us to characterise severe asthma phenotypes in the real-world setting and provide insight into patient eligibility and suitability for new and emerging targeted treatments.
  • Biologic treatments and procedures like bronchial thermoplasty (BT) are being evaluated through severe asthma registries.
  • Severe asthma networks, such as the Australasian Severe Asthma Network (ASAN), facilitate the multi-centre and standardised data collection required for severe asthma registries.
Read more

Last Updated on February 11, 2019

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

More results...

  • Australasian Severe Asthma Registry
  • Australian Mepolizumab Registry (AMR)
  • Australian Xolair Registry (AXR)

We want to know who accesses the Severe Asthma Toolkit and how it is used. Please complete our survey.

Responses will inform the continued development of the Severe Asthma Toolkit and future translation and implementation activities. Any feedback you provide will be greatly appreciated.

Complete Survey

  • Website Terms of Use
  • Website Survey
© Copyright 2018    CRICOS Provider Number 00109J    The University of Newcastle, Australia